Petros I. Rafailidis

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou et al. · Journal of Clinical Investigation · 2020 · 798 citations · Full text

Medicine, Immunology, Pathology +17

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

Matthew E. Falagas, Petros I. Rafailidis, Elda Ioannidou et al. · International Journal of Antimicrobial Agents · 2009 · 298 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study

Matthew E. Falagas, Petros I. Rafailidis, Diamantis P. Kofteridis et al. · Journal of Antimicrobial Chemotherapy · 2007 · 252 citations

Life Sciences, Infectious Diseases, Antimicrobial Resistance +16

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

Matthew E. Falagas, Petros I. Rafailidis · Critical Care · 2007 · 204 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study

Sophia L. Markantonis, Efthimios Dimitrakis, Dimitrios Panidis et al. · Clinical Therapeutics · 2008 · 189 citations

Nursing, Infectious Diseases, Pharmacokinetics +13